IMMUNOPHILIN AND RELATED PROTEINS
亲免素及相关蛋白质
基本信息
- 批准号:2633541
- 负责人:
- 金额:$ 23.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-01-01 至 1999-06-30
- 项目状态:已结题
- 来源:
- 关键词:FK506 Sf9 cell line adenosine triphosphate affinity chromatography chemical association confocal scanning microscopy corticosteroid receptors drug receptors immunofluorescence technique immunoprecipitation immunosuppressive intermolecular interaction laboratory rabbit molecular cloning molecular size peptidylprolyl isomerase phosphoproteins phosphorylation protein kinase protein purification protein reconstitution protein sequence protein structure function sirolimus site directed mutagenesis stress proteins
项目摘要
Binding proteins for immunosuppressant drugs have been discovered recently
in connection with the oligomeric structures of cytoplasmic steroid
receptors. The binding proteins form complexes with known
immunosuppressant drugs, such as rapamycin, FK5O6 and cyclosporin A and
because there are elevations and declines in the functioning of the immune
system with aging and other conditions, it seems likely that there exist
one or more endogenous immunosuppressant agents whose levels may be under
various types of control. In studying the reassembly of the
glucocorticoid receptor non-DNA-binding complex form with purified
proteins, we discovered a new protein complexed with the FKBP-52 (p55-59)
immunophilin. Because this new protein is purified with the FKBP-52 from
different cell lines and it appears only when FKBP-52 appears, we conclude
that it may function in the signal transduction pathway of
immunosuppressant action. Consequently, we plan to pursue the following
objectives: (1) Full-length, truncated and mutated FKBP-52 will be
overexpressed in the baculovirus system. Site directed mutagenesis will be
followed by overexpression of the mutant proteins and all of these
proteins will be purified. (2) Overexpressed and purified FKBP-52, hsp90,
hsp7O and other cytosolic factors will be reconstituted into high
molecular weight complexes, comparable to cellular complexes, and the
effects of immunosuppressant drug ligands on these complexes will be
assessed. (3) The 59kDa FKBP-52-associated new phosphoprotein will be
cloned, overexpressed, purified and characterized. (4) The sequences in
FKBP-52 that are responsible for binding to hsp9O, hsp7O, ATP and the
59kDa FKBP-52-associated protein will be determined by mutation of the
FKBP-52 cDNA, overexpression of the derivative protein and assembly into
the high molecular weight complex. (5) Specific antibodies against FKBP-
52 and its associated phosphoprotein will be developed. These experiments
will clarify the signal transduction process involved in the pathway of
drug-induced immunosuppression and may contribute to the methods required
to discover the endogenous immunosuppressants, results that will directly
affect organ and tissue transplantation.
免疫抑制剂药物的结合蛋白是最近发现的
与细胞质类固醇的寡聚体结构有关,
受体。结合蛋白与已知的
免疫抑制药物,如雷帕霉素、FK 5 O 6和环孢菌素A,
因为免疫系统的功能有升有降
随着年龄的增长和其他条件的系统,似乎有可能存在
一种或多种内源性免疫抑制剂,其水平可低于
各种控制。 在研究重新组装的
糖皮质激素受体非DNA结合复合物形式与纯化
我们发现了一种新的与FKBP-52(p55-59)复合的蛋白质
亲免素。 因为这种新蛋白质是用来自
不同的细胞系,它只出现在FKBP-52出现时,我们得出结论,
它可能在信号转导途径中起作用,
免疫抑制作用。 因此,我们计划开展以下工作:
目的:(1)全长、截短和突变的FKBP-52将被
在杆状病毒系统中过表达。定点诱变将是
然后是突变蛋白的过度表达,
蛋白质将被纯化。(2)过量表达和纯化的FKBP-52、hsp 90、
hsp 70和其它胞质因子将被重新构建成高水平的
分子量复合物,与细胞复合物相当,
免疫抑制药物配体对这些复合物的作用将是
评估。(3)59 kDa FKBP-52相关的新磷蛋白将被
克隆、过表达、纯化和表征。(4)中的序列
FKBP-52负责结合hsp 9 O、hsp 7 O、ATP和HSP 7 O。
59 kDa FKBP-52-相关蛋白将通过突变FKBP-52-相关蛋白来确定。
FKBP-52 cDNA,衍生蛋白的过表达和组装成
高分子量复合物。 (5)FKBP特异性抗体-
52及其相关的磷蛋白将被开发。 这些实验
将阐明信号转导过程中涉及的途径,
药物诱导的免疫抑制,并可能有助于所需的方法
发现内源性免疫抑制剂,结果将直接
影响器官和组织移植。
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
FKBP46, a novel Sf9 insect cell nuclear immunophilin that forms a protein-kinase complex.
- DOI:10.1016/s0021-9258(18)47356-5
- 发表时间:1994-12
- 期刊:
- 影响因子:0
- 作者:E. Alnemri;T. Fernandes‐Alnemri;K. Pomerenke;N. Robertson;K. Dudley;G. Dubois;G. Litwack
- 通讯作者:E. Alnemri;T. Fernandes‐Alnemri;K. Pomerenke;N. Robertson;K. Dudley;G. Dubois;G. Litwack
CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP.
- DOI:
- 发表时间:1997-02
- 期刊:
- 影响因子:11.2
- 作者:Manzoor Ahmad;S. Srinivasula;Lijuan Wang;R. Talanian;G. Litwack;T. Fernandes‐Alnemri;E. Alnemri
- 通讯作者:Manzoor Ahmad;S. Srinivasula;Lijuan Wang;R. Talanian;G. Litwack;T. Fernandes‐Alnemri;E. Alnemri
Chromosomal mapping of cell death proteases CPP32, MCH2, and MCH3.
细胞死亡蛋白酶 CPP32、MCH2 和 MCH3 的染色体作图。
- DOI:10.1006/geno.1996.0476
- 发表时间:1996
- 期刊:
- 影响因子:0
- 作者:Bullrich,F;Fernandes-Alnemri,T;Litwack,G;Alnemri,ES;Croce,CM
- 通讯作者:Croce,CM
An immunophilin is a component of the insect ecdysone receptor (EcR) complex.
亲免素是昆虫蜕皮激素受体 (EcR) 复合物的组成部分。
- DOI:10.1016/s0965-1748(97)00080-5
- 发表时间:1997
- 期刊:
- 影响因子:3.8
- 作者:Song,Q;Alnemri,ES;Litwack,G;Gilbert,LI
- 通讯作者:Gilbert,LI
CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme.
- DOI:10.1016/s0021-9258(18)47344-9
- 发表时间:1994-12
- 期刊:
- 影响因子:0
- 作者:T. Fernandes‐Alnemri;G. Litwack;E. Alnemri
- 通讯作者:T. Fernandes‐Alnemri;G. Litwack;E. Alnemri
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GERALD LITWACK其他文献
GERALD LITWACK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GERALD LITWACK', 18)}}的其他基金
TRAINING PROGRAM IN BIOMOLECULAR SIGNAL TRANSDUCTION
生物分子信号转导培训计划
- 批准号:
6516898 - 财政年份:1994
- 资助金额:
$ 23.87万 - 项目类别:
TRAINING PROGRAM IN BIOMOLECULAR SIGNAL TRANSDUCTION
生物分子信号转导培训计划
- 批准号:
6380306 - 财政年份:1994
- 资助金额:
$ 23.87万 - 项目类别:
TRAINING PROGRAM IN BIOMOLECULAR SIGNAL TRANSDUCTION
生物分子信号转导培训计划
- 批准号:
2135361 - 财政年份:1994
- 资助金额:
$ 23.87万 - 项目类别:
TRAINING PROGRAM IN BIOMOLECULAR SIGNAL TRANSDUCTION
生物分子信号转导培训计划
- 批准号:
2713327 - 财政年份:1994
- 资助金额:
$ 23.87万 - 项目类别:
TRAINING PROGRAM IN BIOMOLECULAR SIGNAL TRANSDUCTION
生物分子信号转导培训计划
- 批准号:
2135362 - 财政年份:1994
- 资助金额:
$ 23.87万 - 项目类别:














{{item.name}}会员




